Trial site
Community Cancer Trials of Utah
- 9running trials
- 7closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Chronic myeloid leukaemia2 trials
- Diffuse large B-cell lymphoma2 trials
- Myeloproliferative neoplasms2 trials
- Pancreatic cancer2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- and 6 more
- Phase
- Phase 38 trials
- Phase 26 trials
- Phase 1/21 trial
- Status
- Active, not recruiting7 trials
- Completed5 trials
- Recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals3 trials
- Regeneron Pharmaceuticals2 trials
- Aadi Bioscience, Inc.1 trial
- Amgen1 trial
- Boehringer Ingelheim1 trial
- and 8 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma1 recruiting
- Lung cancer1 recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Completed
XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 18 Nov 2026